HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
Rosa Sottile(Karolinska Institutet), Ennio Carbone(Karolinska Institutet)
Cited by 37
Related Papers
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
|Journal of Clinical Investigation|2009|331
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
|Cell Cycle|2011|118
New views on natural killer cell-based immunotherapy for melanoma treatment
|Trends in Immunology|2010|92